1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics, June 2017 (p5)

Biotechnology Analysis & Statistics, June 2017 (p5)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

All regions

121-150 of about 3600 reports

Purchase Reports From Reputable Market Research Publishers

Interleukin 1 (IL1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Interleukin 1 (IL1) - Pipeline Review, H1 2017 Summary Interleukin 1 (IL1) pipeline Target constitutes close to 28 molecules. Out of which approximately 27 molecules are developed by companies and remaining ...

  • Industries : Therapy, Pathology, Cancer, Pharmaceutical
  • Countries : World, United States, Europe

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H1 2017 Summary According to the recently published report 'T Cell Surface Glycoprotein CD4 - Pipeline Review, ...

  • Industries : Therapy, Pathology
  • Countries : United States, World

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H1 2017 Summary According to the recently published report 'N Sulphoglucosamine ...

  • Industries : Therapy, Biological Therapy, Pathology, Pharmaceutical, Drug Discovery and Development
  • Countries : United States

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H1 2017 Summary T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - CD28 is a proteins expressed on T cells. It co-stimulates ...

  • Industries : Therapy, Biological Therapy, Drug Discovery and Development, Pathology
  • Countries : World, United States

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H1 2017 Summary Alpha L-Iduronidase (IDUA or EC 3.2.1.76) pipeline Target constitutes close to 9 molecules. Out of which approximately 7 molecules ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Pharmaceutical, Biotechnology, Biological Therapy
  • Countries : United States, World

Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H1 2017 Summary According to the recently published report 'Protein Phosphatase 2A - Pipeline Review, H1 2017'; Protein Phosphatase 2A (PP2A ...

  • Industries : Therapy, Pathology, Cancer
  • Countries : United States

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H1 2017 Summary Toll Like Receptor 3 (CD283 or TLR3) pipeline Target constitutes close to 14 molecules. Out of which approximately 10 molecules are ...

  • Industries : Pathology, Cancer
  • Countries : World, United States

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2017 Summary According to the recently published report 'Integrin Beta ...

  • Industries : Therapy, Health Services, Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : World, United States

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H1 2017 Summary Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States, World

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2017 Summary According to the recently published ...

  • Industries : Cancer, Pathology, Biological Therapy, Therapy
  • Countries : United States, World

Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H1 2017 Summary According to the recently ...

  • Industries : Pathology, Therapy, Health Services, Cancer
  • Countries : World

US Market Report for Dental Bone Graft Substitutes 2017 - MedCore

  • $ 3495
  • Industry report
  • July 2017
  • by iData Research, Inc.

General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapter segment - ...

  • Industries : Advanced Material, Biomaterial, Biomaterial
  • Countries : United States

Gene Therapy Ophthalmology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2017

  • $ 2950
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s report, “Gene Therapy Ophthalmology Insight - Pipeline Assessment, Market Trend, Technology and Competitive Landscape, 2017” emphasizes on the currently under development Gene Therapy ...

  • Industries : Biological Therapy

Natural Killer Cells -Competitive Landscape, Technology and Pipeline Analysis, 2017

  • $ 2750
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s, “Natural Killer Cells- Competitive Landscape, Pipeline and Market Analysis, 2017”, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of ...

  • Industries : Therapy, Biological Therapy

Blood Purification Equipment - Medical Devices Pipeline Assessment, 2017

  • $ 2500
  • Industry report
  • August 2017
  • by GlobalData

Blood Purification Equipment - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Blood Purification Equipment - Medical Devices Pipeline Assessment, 2017" ...

  • Industries : Healthcare, Pharmaceutical, Pathology, Drug Discovery and Development, Health Services
  • Countries : United States

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview ...

  • Industries : Cancer, Pathology
  • Countries : World

Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2017" provides ...

  • Industries : Pathology, Therapy, Healthcare, Pharmaceutical, Drug Discovery and Development
  • Countries : World

Critical Limb Ischemia Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Critical Limb Ischemia Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Critical Limb Ischemia Global Clinical Trials Review, H2, 2017" provides an overview of Critical ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy, Health Services
  • Countries : World

Cystic Fibrosis Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Cystic Fibrosis Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Cystic Fibrosis Global Clinical Trials Review, H2, 2017" provides an overview of Cystic Fibrosis ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Pathology
  • Countries : World, United States

Crohn’s Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Crohn’s Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Crohn’s Disease (Regional Enteritis) Global Clinical Trials Review, H2, ...

  • Industries : Therapy, Pathology, Pharmaceutical, Drug Discovery and Development, Healthcare
  • Countries : World

Pancreatic Cancer - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Pancreatic Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H1 2017, provides an overview ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Human Immunodeficiency Virus ...

  • Industries : Pathology, Healthcare
  • Countries : United States

Rheumatoid Arthritis - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Rheumatoid Arthritis - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H1 2017, provides an ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) - Pipeline Review, ...

  • Industries : Cancer, Pathology, Healthcare
  • Countries : United States

Ovarian Cancer - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Ovarian Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H1 2017, provides an overview of ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

Melanoma - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Melanoma - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Melanoma - Pipeline Review, H1 2017, provides an overview of the Melanoma ...

  • Industries : Therapy, Cancer, Pathology, Pharmaceutical, Biotechnology
  • Countries : United States, North America

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) - Pipeline Review, ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

Prostate Cancer - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Prostate Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Pipeline Review, H1 2017, provides an overview ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

Colorectal Cancer - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Colorectal Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Pipeline Review, H1 2017, provides an overview ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.